A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Linezolid D3 | CAS 1127120-38-0 - Request Quote

Picture of Linezolid D3

Linezolid D3

SZ CAT No:SZ-L025D01
CAS No
1127120-38-0
Mol.F.
C16H17D3FN3O4
Mol.Wt.
340.4
Inv. Status
Under Synthesis
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Linezolid D3 is chemically (S)-N-((3-(3-fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl)acetamide-2,2,2-d3. Linezolid D3 is supplied with detailed characterization data compliant with regulatory guideline. Linezolid D3 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Linezolid.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1127120-38-0

Purchase 1127120-38-0

Order 1127120-38-0

Enquire 1127120-38-0

price of 1127120-38-0

1127120-38-0 Supplier

1127120-38-0 Manufacturer

1127120-38-0 Exporter

buy high quality Linezolid D3

Purchase Linezolid D3

Linezolid D3 suppliers

Linezolid D3 manufacturers

Linezolid D3 price

Order Linezolid D3

Enquire Linezolid D3

Linezolid D3 cost

Linezolid D3 Supplier

Linezolid D3 Distributor

Linezolid D3 for Method Validation

Linezolid Reference Standard

Linezolid D3 for ANDA Filing

Linezolid D3 for Forced Degradation Studies

Linezolid D3 Identification Standards

Linezolid D3 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,